JP2019500403A5 - - Google Patents

Download PDF

Info

Publication number
JP2019500403A5
JP2019500403A5 JP2018538068A JP2018538068A JP2019500403A5 JP 2019500403 A5 JP2019500403 A5 JP 2019500403A5 JP 2018538068 A JP2018538068 A JP 2018538068A JP 2018538068 A JP2018538068 A JP 2018538068A JP 2019500403 A5 JP2019500403 A5 JP 2019500403A5
Authority
JP
Japan
Prior art keywords
crosslinked
particles
drug
occurrence
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019500403A (ja
JP6852079B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/056135 external-priority patent/WO2017062871A1/en
Publication of JP2019500403A publication Critical patent/JP2019500403A/ja
Publication of JP2019500403A5 publication Critical patent/JP2019500403A5/ja
Priority to JP2021037974A priority Critical patent/JP7104198B2/ja
Application granted granted Critical
Publication of JP6852079B2 publication Critical patent/JP6852079B2/ja
Priority to JP2022109826A priority patent/JP7500659B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538068A 2015-10-09 2016-10-07 架橋粒子 Active JP6852079B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021037974A JP7104198B2 (ja) 2015-10-09 2021-03-10 架橋粒子
JP2022109826A JP7500659B2 (ja) 2015-10-09 2022-07-07 架橋粒子

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562239758P 2015-10-09 2015-10-09
US62/239,758 2015-10-09
US201662281631P 2016-01-21 2016-01-21
US62/281,631 2016-01-21
US201662313013P 2016-03-24 2016-03-24
US62/313,013 2016-03-24
PCT/US2016/056135 WO2017062871A1 (en) 2015-10-09 2016-10-07 Crosslinked particles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021037974A Division JP7104198B2 (ja) 2015-10-09 2021-03-10 架橋粒子

Publications (3)

Publication Number Publication Date
JP2019500403A JP2019500403A (ja) 2019-01-10
JP2019500403A5 true JP2019500403A5 (cg-RX-API-DMAC7.html) 2019-11-14
JP6852079B2 JP6852079B2 (ja) 2021-03-31

Family

ID=58488602

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018538068A Active JP6852079B2 (ja) 2015-10-09 2016-10-07 架橋粒子
JP2021037974A Active JP7104198B2 (ja) 2015-10-09 2021-03-10 架橋粒子
JP2022109826A Active JP7500659B2 (ja) 2015-10-09 2022-07-07 架橋粒子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021037974A Active JP7104198B2 (ja) 2015-10-09 2021-03-10 架橋粒子
JP2022109826A Active JP7500659B2 (ja) 2015-10-09 2022-07-07 架橋粒子

Country Status (7)

Country Link
US (3) US10258578B2 (cg-RX-API-DMAC7.html)
EP (2) EP4019575B1 (cg-RX-API-DMAC7.html)
JP (3) JP6852079B2 (cg-RX-API-DMAC7.html)
CN (1) CN109843996B (cg-RX-API-DMAC7.html)
AU (2) AU2016335866B2 (cg-RX-API-DMAC7.html)
ES (2) ES2906596T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017062871A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4019575B1 (en) 2015-10-09 2023-12-06 Le Dévédec, Frantz Crosslinked particles
US11905377B2 (en) 2019-01-17 2024-02-20 Pendant Biosciences, Inc. Factors controlling drug release in cross-linked poly(valerolactone) based matrices
WO2021127623A1 (en) * 2019-12-19 2021-06-24 Pendant Biosciences, Inc. Crosslinked pla-based copolymers
US20250215215A1 (en) * 2022-03-29 2025-07-03 Kaneka Corporation Thermoplastic resin composition
EP4506395A4 (en) * 2022-03-29 2026-04-15 Kaneka Corp CROSS-CUT RESIN PARTICLES AND THEIR PRODUCTION PROCESS
US20250388748A1 (en) * 2022-03-29 2025-12-25 Kaneka Corporation Thermoplastic resin composition
JPWO2025075122A1 (cg-RX-API-DMAC7.html) * 2023-10-04 2025-04-10

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003219922B2 (en) * 2002-02-27 2009-09-10 Pharmain Corporation Compositions for delivery of therapeutics and other materials, and methods of making and using the same
US6800663B2 (en) * 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
US8808681B2 (en) 2006-06-05 2014-08-19 Massachusetts Institute Of Technology Crosslinked, degradable polymers and uses thereof
CN100546661C (zh) * 2006-12-01 2009-10-07 华南理工大学 一种原位成孔自固化磷酸钙复合组织工程支架的制备方法
US20130142733A1 (en) * 2007-11-05 2013-06-06 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US20110274620A1 (en) * 2007-11-05 2011-11-10 Harth Eva M Multifunctional degradable nanoparticles with control over size and functionalities
DK2209496T3 (da) 2007-11-05 2019-08-05 Univ Vanderbilt Multifunktionelle nedbrydelige nanopartikler med kontrol over størrelse og funktioner
CN103003260A (zh) 2009-12-21 2013-03-27 赢创德固赛有限公司 用于制备包含不饱和官能团的环酯的方法和由其制备的聚酯
WO2013169938A2 (en) * 2012-05-08 2013-11-14 Vanderbilt University Polycarbonate containing compounds and methods related thereto
ITTO20130431A1 (it) * 2013-05-28 2014-11-29 Fond Istituto Italiano Di Tecnologia Copolimero e nanoparticelle da esso ottenute per la veicolazione di un farmaco
WO2016174116A1 (en) 2015-04-27 2016-11-03 Eggplant S.R.L. Polyester composition and method for producing the same
EP4019575B1 (en) 2015-10-09 2023-12-06 Le Dévédec, Frantz Crosslinked particles

Similar Documents

Publication Publication Date Title
JP7500659B2 (ja) 架橋粒子
JP2019163341A (ja) 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス
WO2008095256A1 (en) Hollow microparticles
JP2017520567A5 (cg-RX-API-DMAC7.html)
US11731099B2 (en) Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
Guo et al. A facile fabrication of core–shell sodium alginate/gelatin beads for drug delivery systems
CN111417459A (zh) 一种新型可载药微球及其制备方法
WO2020227350A1 (en) Random copolymer stabilized nanoparticles encapsulating soluble hydrophilic compounds
JP2022130727A5 (cg-RX-API-DMAC7.html)
Huang et al. Fabrication and process investigation of vancomycin loaded silica xerogel/polymer core–shell composite nanoparticles for drug delivery
DE102005051366A1 (de) Drug Delivery Systeme
CN103951837A (zh) 一种壳聚糖水凝胶微球的制备方法
JP2017501023A (ja) 機能性物質を含む高分子微細カプセル及びその製造方法
Akgün et al. Perspectives of Aerosol‐Photopolymerization: Nanostructured Polymeric Particles
JP5845044B2 (ja) 硬化剤及び/又は硬化促進剤内包カプセル、及び、熱硬化性樹脂組成物
Huda et al. Synthesis of poly (n-octadecyl methacrylate-co-2-hydroxyethyl methacrylate) copolymer and their utilization as polymeric stabilizer in the preparation of PCL microspheres
Han et al. Facile preparation of PLGA microspheres with diverse internal structures by modified double‐emulsion method for controlled release
Sivakumaran et al. Fabricating degradable thermoresponsive hydrogels on multiple length scales via reactive extrusion, microfluidics, self-assembly, and electrospinning
CN104231137A (zh) 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法
Kashyap et al. Copolymer with long chain alkyl group as stabilizer in the preparation of biodegradable polyester particle
HK40009686A (en) Crosslinked particles
Das et al. Amphiphilic copolymeric stabilizer for the formation of polycaprolactone particles
TW201720875A (zh) 可生物降解高分子微載體成型方法
JP2001192439A (ja) 生体内分解型高分子重合物